Lipid metabolism in critical illness

被引:53
|
作者
Green, Pnina [1 ]
Theilla, Miriam [2 ,3 ]
Singer, Pierre [1 ,3 ]
机构
[1] Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Felsenstein Med Res Ctr,Metab Lab, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Nursing Dept,Steyer Sch Hlth Profess, IL-69978 Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Gen Intens Care Dept,Inst Nutr Res,Rabin Med Ctr, IL-69978 Tel Aviv, Israel
关键词
critical illness; fish oil; lipid metabolism; RANDOMIZED CONTROLLED-TRIAL; GAMMA-LINOLENIC ACID; ACUTE LUNG INJURY; FISH-OIL; EXPERIMENTAL ENDOTOXEMIA; ILL PATIENTS; PLASMA;
D O I
10.1097/MCO.0000000000000253
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of reviewThis article describes recent findings regarding lipid metabolism in critical illness as well as in lipid therapy.Recent findingsIn critical illness, in the presence of a decrease in lipid absorption, adipose tissue lipolysis raises triglyceride levels. High-density lipoprotein and low-density lipoprotein are decreased because of impairment of lecithin-cholesterol acyltransferase, mainly in sepsis. In septic patients, lipid profile may be a predictor of survival. Nonsurvivors have lower levels of high-density lipoprotein and low-density lipoprotein. In metabolomic studies, most of the changes from baseline in septic patients were related to lipid metabolism. Lysophosphatidylcholine was also significantly lower in nonsurviving septic patients.SummaryLipid profile results are too often neglected by the clinician despite increasing knowledge in the modifications related to septic state as well as the importance of these values in the prognosis of the critically ill. Lipid administration (enterally or parenterally) should be guided by better knowledge of the lipid metabolism of the patient.
引用
收藏
页码:111 / 115
页数:5
相关论文
共 50 条
  • [1] Protein metabolism in critical illness
    Wernerman, J
    Hammarqvist, F
    Gamrin, L
    Essen, P
    [J]. BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1996, 10 (04): : 603 - 615
  • [2] Protein metabolism in critical illness
    Chapple, Lee-anne S.
    van Gassel, Rob J. J.
    Rooyackers, Olav
    [J]. CURRENT OPINION IN CRITICAL CARE, 2022, 28 (04) : 367 - 373
  • [3] LIPID METABOLISM DURING INFECTIOUS ILLNESS
    BEISEL, WR
    FISER, RH
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1970, 23 (08): : 1069 - &
  • [4] Lipid mediators in the pathophysiology of critical illness
    Bulger, EM
    Maier, RV
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (04) : N27 - N36
  • [5] Hepatic drug metabolism in critical illness
    McKindley, DS
    Hanes, S
    Boucher, BA
    [J]. PHARMACOTHERAPY, 1998, 18 (04): : 759 - 778
  • [6] LIMITS OF AEROBIC METABOLISM IN CRITICAL ILLNESS
    LISTER, G
    GUTIERREZ, G
    CAIN, SM
    SCHUMACKER, PT
    WOOD, LDH
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1985, 131 (01): : 192 - 193
  • [7] LIMITATIONS OF AEROBIC METABOLISM IN CRITICAL ILLNESS
    SCHUMACKER, PT
    WOOD, LDH
    [J]. CHEST, 1984, 85 (04) : 453 - 454
  • [8] Aberrant bone metabolism in critical illness
    I Vanhees
    L Solie
    SJ Roberts
    A Wauters
    J Gunst
    F Luyten
    S Van Cromphaut
    G Van den Berghe
    HC Owen
    [J]. Critical Care, 16 (Suppl 1):
  • [9] Lipid emulsions for parenteral nutrition in critical illness
    Boisrame-Helms, Julie
    Toti, Florence
    Hasselmann, Michel
    Meziani, Ferhat
    [J]. PROGRESS IN LIPID RESEARCH, 2015, 60 : 1 - 16
  • [10] Reduced Cortisol Metabolism during Critical Illness
    Cooper, Mark S.
    Thickett, David R.
    Stewart, Paul M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (05): : 480 - 480